Antiviral Research

Retroviral integrase inhibitors year 2000: update and perspectives
pp. 139-148(10)
Authors: Pommier Y.; Marchand C.; Neamati N.

A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex Virus
pp. 149-158(10)
Authors: Franchetti P.; Abu Sheikha G.; Cappellacci L.; Marchetti S.; Grifantini M.; Balestra E.; Perno C.-F.; Benatti U.; Brandi G.; Rossi L.; Magnani M.

Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations
pp. 159-169(11)
Authors: Bernstein D.I.; Ireland J.; Bourne N.

Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir
pp. 171-177(7)
Authors: Smee D.F.; Bailey K.W.; Wong M.-H.; Sidwell R.W.

The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients
pp. 179-188(10)
Authors: Karmochkine M.; Si Mohamed A.; Piketty C.; Ginsburg C.; Raguin G.; Schneider-Fauveau V.; Gutmann L.; Kazatchkine M.D.; Belec L.

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment
pp. 189-198(10)
Authors: Vella S.; Galluzzo M.C.; Giannini G.; Pirillo M.F.; Andreotti M.; Tomino C.; Fragola V.; Bucciardini R.; Ricciardulli D.; Binelli A.; Weimer L.E.; Floridia M.

Development of screening systems for drugs against human papillomavirus-associated cervical cancer: based on E6-E6AP binding
pp. 199-206(8)
Authors: Cho Y.-S.; Cho C.-W.; Joung O.; Lee K.-A.; Park S.-N.; Yoon D.-Y.

Cellular zinc status regulates cytomegalovirus major immediate-early promoter
pp. 207-214(8)
Authors: Kanekiyo M.; Itoh N.; Mano M.; Kawasaki A.; Tanaka J.; Muto N.; Tanaka K.

In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses
pp. 215-220(6)
Authors: Kaiser L.; Crump C.E.; Hayden F.G.